#COVID impacted #revenue & #profit, #FY23 core business saw 13% volume growth (ex-COVID). Despite opening 15 #labs in #FY23, #margin dilution was at 1.5%. New network contribution to increase from 3% to 5%, says Ameera Shah of Metropolis Health